OABI
OmniAb Inc.
NASDAQ: OABI · HEALTHCARE · BIOTECHNOLOGY
$1.36
-2.86% today
Updated 2026-04-29
Market cap
$208.49M
P/E ratio
—
P/S ratio
11.17x
EPS (TTM)
$-0.57
Dividend yield
—
52W range
$1 – $2
Volume
0.4M
OmniAb Inc. (OABI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $18.32M | $23.27M | $34.75M | $59.08M | $34.16M | $26.39M | $18.67M |
| Revenue growth (YoY) | — | +27.0% | +49.3% | +70.0% | -42.2% | -22.8% | -29.3% |
| Cost of revenue | — | — | $14.97M | $16.25M | $19.50M | $19.68M | $22.06M |
| Gross profit | $18.32M | $23.27M | $34.75M | $59.08M | $34.16M | $26.39M | $-3.39M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -18.2% |
| R&D | $13.21M | $24.80M | $39.23M | $48.36M | $56.52M | $55.11M | $47.75M |
| SG&A | $8.65M | $10.22M | $16.95M | $24.90M | $33.31M | $30.74M | $29.21M |
| Operating income | $-13.03M | $-25.62M | $-35.61M | $-26.65M | $-69.42M | $-74.50M | $-71.52M |
| Operating margin | -71.1% | -110.1% | -102.5% | -45.1% | -203.2% | -282.3% | -383.1% |
| EBITDA | $-3.25M | $-10.93M | $-18.09M | $-8.40M | $-49.92M | $-50.92M | $-49.76M |
| EBITDA margin | -17.8% | -47.0% | -52.1% | -14.2% | -146.1% | -192.9% | -266.6% |
| EBIT | $-13.85M | $-23.55M | $-34.34M | $-26.65M | $-69.42M | $-74.50M | $-71.52M |
| Interest expense | $0.00 | $5000.00 | $7000.00 | $587000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.59M | $-17.56M | $-27.04M | $-22.33M | $-50.62M | $-62.03M | $-64.78M |
| Net income growth (YoY) | — | -29.2% | -54.0% | +17.4% | -126.6% | -22.5% | -4.4% |
| Profit margin | -74.2% | -75.5% | -77.8% | -37.8% | -148.2% | -235.1% | -347.0% |